Tirzepatide — sold as Mounjaro and Zepbound — is a dual-action medication that's become one of the most requested weight loss treatments available. Here's how it actually works, how it compares to semaglutide, and what real medical oversight looks like at Abbott.
Tirzepatide was originally developed and FDA-approved in 2022 under the brand name Mounjaro, for type 2 diabetes. In late 2023, the same medication was FDA-approved specifically for chronic weight management under the brand name Zepbound. Both contain the exact same active ingredient — the brand you're prescribed depends on your diagnosis, and your provider will walk through which one fits your situation.
What makes tirzepatide different from single-action GLP-1 medications like semaglutide is its dual mechanism: it acts on both the GLP-1 receptor and a second receptor, GIP, which appears to have an additive effect on appetite regulation and blood sugar control. In practical terms, it's working two of the pathways involved in hunger and metabolism instead of one.
A short clip on how tirzepatide therapy works alongside supportive nutrients.
Both medications work, and both are backed by strong clinical trial data. Clinical trials comparing the two have generally shown tirzepatide producing somewhat greater average weight loss than semaglutide at maximum doses — but that's an average across large study populations, and individual response varies. We help you choose based on your labs and health history, not which name you've heard more often.
Brand names: Zepbound (weight loss), Mounjaro (diabetes). Targets two hormone receptors for enhanced results in many patients.
Brand names: Wegovy (weight loss), Ozempic (diabetes). The most studied GLP-1 medication, FDA-approved for chronic weight management since 2021.
A closer look at mechanism, side effects, cost, and how we decide which medication fits you.
Read the ComparisonSee how tirzepatide fits into a complete plan — labs, body composition tracking, and ongoing support.
Explore Medical Weight Loss"Patients come in asking which medication is 'stronger,' as if that's the only variable that matters. The better question is which one your body will tolerate well enough that you actually stay on it long enough to get results. Tirzepatide's dual mechanism gives it an edge in average trial outcomes, but the right medication is the one that fits your labs, your history, and your life."
Often discussed alongside tirzepatide: Semaglutide, Topamax, Phentermine, and what GLP-1 side effects actually feel like.
What patients ask most before their first appointment.
Book a consultation and we'll review your labs and health history to see whether tirzepatide, semaglutide, or another approach makes the most sense for your goals.